IPO - Initial Public Offerings

Stay updated with latest IPO from us

MANKIND PHARMA LIMITED (MANKIND)

Listing Date is May 8, 2023
Open Date : 25 Apr, 2023   |   Close Date : 27 Apr, 2023
Price Range : ₹ 1026 - ₹ 1080      |   Issue Size : ₹ 4,326.36 Cr
Minimum Order Qty - 13 Equity Shares
Minimum Lot Value - ₹ 14,040
Maximum Lots - 14
MANKIND PHARMA LIMITED (MANKIND)

About Company

  • Mankind Pharma Limited, established in 1991, is a company that specializes in developing, manufacturing, and marketing pharmaceutical formulations
  • Among Mankind Pharma Limited's 36+ brands are Manforce (Rx), Moxikind-CV, Amlokind-AT, Unwanted-Kit, Candiforce, Gudcef, Glimestar-M, Prega News, Dydroboon, Codistar, Nurokind-Gold, Nurokind Plus-RF, Nurokind-LC, Asthakind-DX, Cefakind, Monticope, Telmikind-H, Telmikind, Gudcef-CV, and Unwanted-72.

For RHP (Red Herring Prospectus) - Click here